Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05606016 · ClinicalTrials.gov registry record · NA

Examining How a Facilitated Self-Sampling Intervention and Testing Navigation Intervention Influences COVID-19 Testing

A NA study of COVID-19, sponsored by The University of Texas Health Science Center, Houston.

Completed
Registry status
NA
Development phase
1,232
Enrollment target
3
Study locations

NCT05606016: Completed NA study of COVID-19, sponsored by The University of Texas Health Science Center, Houston.

NCT05606016 is a NA study of COVID-19 that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 1,232 participants, below the 38,461-participant average among 298 other COVID-19 trials with a reported enrollment target (97% lower). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05606016, a NA study of COVID-19, has completed, sponsored by The University of Texas Health Science Center, Houston.

COMPLETED
Registry status
NA
Development phase
1,232 participants
Enrollment target
3
Study locations

Study Summary

Antigen self-testing kits are more available at this stage in the pandemic, but among vulnerable populations, use is still low and instructions for antigen testing are not typically designed for low health literacy populations. Studies are needed to explore access and use of antigen tests among vulnerable populations and examine if low-health-literacy-designed interventions improve COVID-19 testing decisions and behaviors. This study will focus on understanding factors associated with rapid COVID-19 testing, specifically. The primary objectives of the embedded study are to 1) Determine the effectiveness of community-level intervention using door-to-door recruitment and education in increasing COVID-19 testing and 2) Compare the effectiveness of the CHW- Facilitated Self-Sampling Intervention (FSSI) vs. CHW Testing Navigation Intervention (TNI).

Primary Outcome

Percent of participants from each study arm who complete testing (antigen or PCR)

Conditions Studied

Interventions

  • BEHAVIORAL Control
  • BEHAVIORAL Facilitated Self-Sampling Intervention (FSSI)
  • BEHAVIORAL Testing Navigation Intervention (TNI).

Study Locations (3)

Texas

  • The University of Texas Health Science Center, Brownsville - Brownsville
  • The University of Texas Health Science Center, Houston - Houston
  • University of Texas Health Science Center,Tyler - Tyler

Trial Details

FieldValue
Enrollment Target 1,232 participants
Start Date 2023-03-30
Est. Completion 2024-08-14
Phase NA

What the finished NCT05606016 record still lists

NCT05606016 is an interventional study that assigns participants to a tested intervention. Its 1,232 participants enrollment target places it among the larger protocols in the corpus, below the 38,461-participant average among 298 other COVID-19 trials with a reported enrollment target (97% lower).

The record links to 1 condition, with COVID-19 appearing as the primary indexed condition, and to 3 interventions - of which Control is the first listed.

NCT05606016 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT05606016 about?

NCT05606016 is a clinical study titled "Examining How a Facilitated Self-Sampling Intervention and Testing Navigation Intervention Influences COVID-19 Testing". Antigen self-testing kits are more available at this stage in the pandemic, but among vulnerable populations, use is still low and instructions for antigen testing are not typically designed for low health literacy populations. Studies are needed to explore access and use of antigen tests among vuln...

What is the current status of trial NCT05606016?

This trial is currently completed. It is a NA study. The enrollment target is 1,232 participants. The study started on 2023-03-30. Estimated completion is 2024-08-14.

What conditions does trial NCT05606016 study?

This clinical trial studies the following conditions: COVID-19.

What interventions are being tested in trial NCT05606016?

The interventions under investigation include: Control (BEHAVIORAL), Facilitated Self-Sampling Intervention (FSSI) (BEHAVIORAL), Testing Navigation Intervention (TNI). (BEHAVIORAL).

Who is sponsoring clinical trial NCT05606016?

This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05606016 being conducted?

This trial has 3 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for COVID-19

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05606016's enrollment target sits among peer trials

1,232 61st of 298 higher than 238 of 298 other COVID-19 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other COVID-19 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05456841 · 1,232 participants · NA

    Empathic Communication Skills (ECS) Training

  • NCT05946044 · 1,230 participants · NA

    The Osteoarthritis Prevention Study

  • NCT06787937 · 1,230 participants · NA

    Communicating About Nicotine Reduction in Cigarettes

  • NCT06368245 · 1,244 participants

    Durability of Suppl. Rod Constructs-SuppleMentAry Rod Technique for Long-segment Posterior Instrumented Spinal Fusions

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05606016, the US trial registry maintained by the National Library of Medicine. NCT05606016 (large enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.